|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Polymorphonuclear leukocytes (PMN) are involved in acute lung injury during adult respiratory distress syndrome (ARDS) via several mechanisms. This study focuses on neutrophil-derived oxidative stress. The influence of (A), continuous hypochlorous acid (HOCl) infusion over 105 min and (B) stimulation of PMN having been delayed in the pulmonary microvasculature were studied. Therefore pulmonary artery pressure (PAP), capillary filtration coefficient (Kf,c), and fluid retention (
W) were
monitored using isolated rabbit lungs. These models (A/B) were compared with each other to assess the reproducibility of neutrophil-derived oxidative stress by HOCl. A: Infusion of 250/500/1,000/
2,000 nmol/min HOCl (n = 6/group) evoked a
PAPmax of 0.4 ± 0.07/2.4 ± 0.21/4.9 ± 0.29/4.6 ± 0.25 mm Hg at 105/105/56.4 ± 5.6/21.5 ± 0.8 min and a tenfold increase in Kf,c/
W at 60 min. B:
Stimulation of PMN (1,480 ± 323/µl, n = 8), which were added into the perfusate and sequestrated
in the microvasculature, with 1 µM FMLP resulted in a
PAPmax = 8.4 ± 1.1 torr (t = 3.7 ± 0.19 min)
and a twofold increase in Kf,c/
W (t = 60 min) that were accompanied by a myeloperoxidase (MPO)- release (MPOmax = 56.1 ± 7.3 mU/l, after 1 to 3 min). There was a strong correlation between
PAPmax and MPOmax (r = 0.97, p < 0.01). Both models of neutrophil-derived oxidative stress evoked changes in pulmonary circulation providing evidence for an involvement of PMN via their major oxidant HOCl in pulmonary hypertension and edema during ARDS.
| |
INTRODUCTION |
|---|
|
|
|---|
Acute lung injury during adult respiratory distress syndrome (ARDS) is characterized by an increase in pulmonary capillary permeability (1) leading to non-cardiogenic pulmonary edema and by an increase in pulmonary artery pressure (PAP) causing an alteration of right ventricular function (4, 5). Although ARDS can occur under neutropenic conditions (6, 7) neutrophils have been implicated in the development of acute lung injury (1, 8) and have been identified as key cells that trigger and perpetuate inflammatory processes (12). The release of chemotactic substances from the endothelium and from resident neutrophils causes sequestration of neutrophils in the pulmonary microvasculature (8, 13). This is considered as an initiating event of ARDS (14) and is accompanied by a remarkable increase in the count of neutrophils and of myeloperoxidase (MPO) activity in the bronchioalveolar lavage fluid (14).
Activated neutrophils may affect the surrounding lung tissue via several potentially pathogenic cellular systems including the production of prostanoids (15), the release of lysosomal proteolytic enzymes (11, 16) and the generation of highly reactive oxygen radicals and intermediates (8, 10, 11, 17). During the oxygen burst of neutrophils several highly reactive radicals and intermediates are generated (17). Hypochlorous acid (HOCl) is synthesized by a MPO-mediated reaction from hydrogen peroxide and chloride. It is the main product of activated neutrophils (16) and is much more reactive than hydrogen peroxide (18). Whereas oxygen radicals cause lipid peroxidation of the liquid phase of the cell membrane, which will lead to a nonspecific increase in the membrane permeability and to cell damage, HOCl as non-radical oxidant causes oxidative modification of free functional groups (19) and subsequent functional alteration of proteins (20). Therefore HOCl that is not expected to cause non-specific effects or cell damage due to lipid peroxidation is a useful model of oxidative stress. Different studies deal with the implication of neutrophils in several models of acute lung injury and provide some evidence that neutrophil-induced changes are triggered by reactive oxygen metabolites (21). The arachidonic acid metabolism was found to be stimulated by reactive oxygen metabolites (24). Highly reactive oxygen metabolites are not only released by PMN but also by endothelial cells. Several models of oxidative stress like the xanthine oxidase system generating superoxide radical (26) or hydrogen peroxide (25) have been investigated. These oxidants are released by other sources than neutrophils as well. However the influence of HOCl that is a neutrophil specific oxidant formed by the MPO on the pulmonary microcirculation has not yet been estimated. Therefore this study characterizes on the one hand the effect of continuous HOCl infusion and on the other hand the effect of the activation of neutrophils having been delayed in the pulmonary microvasculature on the circulation in an isolated rabbit lung model. Furthermore it compares the effects of both stimuli to assess the reproducibility of neutrophil-derived oxidative stress by HOCl.
| |
METHODS |
|---|
|
|
|---|
Isolated Rabbit Lung Model
Preparation of isolated rabbit lungs was performed using the method
described in detail by Seeger and coworkers (27). Rabbits of either
sex between 2.5 and 3.5 kg were used. The lungs were ventilated with
4% CO2, 17% O2, and 79% N2 (tidal volume 30 ml, frequency 30 min
1). Perfusion flow was gradually increased to the definite flow rate of 100 ml · min
1 with recirculation of the buffer medium (Krebs-Henseleit buffer, total circulating volume 300 ml). Perfusate temperature was 37° C. Pulmonary arterial pressure (PAP), pulmonary venous
pressure (PVP), inflation pressure and the weight gain of the isolated organ were continuously registered. After a steady-state period of 30 min only those lungs were selected for the study that showed no signs
of leakage at the catheter insertion sights, that had a homogenous
white appearance with no signs of edema formation and that had lost
weight during the phase of temperature increase and were completely
isogravimetric during the steady-state period. After steady-state the
PAP ranged between 7 and 10 mm Hg. The inspiratory peak inflation
pressure was set 7 to 9 mm Hg. The PVP was adjusted to 2 mm Hg.
Hydrostatic Challenge
Capillary filtration coefficient (Kf,c) was determined gravimetrically
from the slope of lung weight gain after a sudden venous pressure
elevation of 10 cm H2O for 8 min (28). Kf,c was related to wet weight
lung (WWL) that was calculated from the body weight (BW) using
WWL = BW · 0.0024. Kf,c was given as 10
4 · ml · s
1 · cm H2O
1 · g
1.
Vascular compliance (C) is defined as the change in vascular volume per change in microvascular pressure. The total rapid change in
weight over the first 1 to 2 min after onset of the venous pressure challenge is taken as pure vascular filling and used for the calculation of
compliance that was given in g · cm H2O
1 (28).
Retention (
W) was determined as remaining difference of weight
before and after a hydrostatic challenge corresponding to the remaining interstitial fluid after normalization of venous pressure and equilibration of a new fluid balance. It is given in grams.
Preparation of PMN
Human PMN were isolated from freshly taken heparinized (10 IU · ml
1) venous blood of normal volunteers. The preparation included dextran enhanced sedimentation, Ficoll-density centrifugation, osmotic lysis of remaining erythrocytes with distilled water. PMN were
washed twice and suspended in Hank's balanced salt solution. The
preparation of PMN were about 98% pure and viable. They were used
within 60 min after preparation.
Experimental Protocol
Two models of oxidative induced lung injury were used: continuous infusion of HOCl and stimulation of neutrophils after having been delayed in the pulmonary microvasculature.
Continuous application of HOCl. The continuous application of
HOCl into the arterial line of the system was started at t = 0 min after
a 30 min steady-state period and after a baseline hydrostatic challenge
at t =
15 min. HOCl that was diluted with perfusate in different concentrations was infused with a constant flow rate of 0.5 ml · min
1, so
that HOCl doses of 250, 500, 1,000, and 2,000 nmol · min
1 were administered. Hydrostatic challenges were performed at 30, 60, and 90 min. The results were compared with a control group with continuous
saline application.
Stimulated neutrophils. Neutrophils were injected into the arterial
line of the preparation at t = 45 min between two steady-state periods
of 30 min and two baseline hydrostatic challenges at t =
60 and t =
15 min. The number of neutrophils added to the perfusate was related to the whole circulating volume and given as cells · µl
1 (360 to
3,025 µl
1). Cell counts withdrawn from the venous line indicated that
the majority of the PMN (about 95%) were sequestrated in the lung after the first passage. The neutrophils were activated by addition of
the chemotactic tripeptide FMLP in a final concentration of 1 µM into
the perfusate. Samples for MPO activity measurement were taken 1, 2, 3, 5, 10, 15, 30, 60, and 90 min after PMN stimulation. Hydrostatic
challenges were performed at 30, 60, and 90 min as well. The results
were compared with control groups either with neutrophil addition
without subsequent FMLP injection (group CI) or with FMLP injection without prior neutrophil addition (group CII). Potassium concentration and lactatedehydrogenase (LDH) activity were measured immediately before hydrostatic challenges in both protocols to show that
no cell damage occurred.
Substances
All reagents were obtained from Sigma (München, Germany). The
concentration of the HOCl stock solution was determined spectrophotometrically (
290 nm = 350 mol
1 · cm
1) immediately before use (29).
Analytical Methods
Concentrations of potassium and LDH activity were performed by clinical routine methods at the Institute of Clinical Chemistry of the University of Göttingen.
The MPO activity was assayed according to the method described
by Klebanoff and coworkers (30). Briefly a sample of 100 µl was
added to 2.9 ml assay solution. This solution was made up daily as follows: 26.9 ml H2O, 3.0 ml 0.1 M sodium phosphate buffer, 0.1 ml 0.1 M
H2O2 and 0.048 ml guaiacol. The production of tetra-guaiacol was
spectrophotometrically measured at 470 nm (
= 26.6 mM
1 · cm
1)
for 5 min.
Statistical Methods
Data are given as mean ± SEM. Analysis for statistical significance was performed by the two-tailed Student's t test for unpaired samples.
| |
RESULTS |
|---|
|
|
|---|
Continuous HOCl Infusion
The time courses of
PAP evoked by continuous HOCl administration and the control group
PAP are shown in Figure
1A. Whereas the time course of
PAP produced by the application of the lowest HOCl dose (250 nmol · min
1) does not
significantly differ from that of the control group, continuous
infusion of 500 to 2,000 nmol · min
1 HOCl causes a dose dependent increase in PAP. As shown in Figure 2A, there is no
significant difference in the baseline PAP between all groups.
The total extent of the pressure rise (given in Figure 2A) as
well as the time of maximum PAP (given in Figure 2B) and the start of the pressure rise (see Figure 1A) is dependent on the HOCl dose. The difference between the maximum PAP
and the baseline PAP (
PAPmax) averages 2.4 ± 0.21 mm Hg,
4.9 ± 0.29 mm Hg, and 4.6 ± 0.25 mm Hg in the 500, 1,000 and
2,000 nmol · min
1 HOCl group. Edema formation that occurred during all experiments except the control group (see
Table 1) resulted in a premature termination of the experiments in the 1,000 and 2,000 nmol · min
1 group. The mean recording times are given in Figure 1B. This premature termination due to edema formation may explain that no further
pressure development is observed in the 1,000 and 2,000 nmol · min
1 group and that there is no significant difference in the
PAPmax between these groups.
|
|
|
The results calculated from the data of the hydrostatic challenges (Kf,c,
W, and C) are presented in Table 1. The influence of HOCl administration on vascular permeability indicated by these data is time and dose dependent as well. Only
slight changes in the vascular permeability are observed in the
250 and 500 nmol · min
1 HOCl group with an up to twofold
increase in Kf,c and
W. The changes in Kf,c and
W due to
higher HOCl doses are more severe and occur earlier. Continuous administration of 1,000 and 2,000 nmol · min
1 results in
an up to tenfold increase in Kf,c. This increase in Kf,c is accompanied by an increase in fluid retention during hydrostatic challenges and by severe edema formation that is reflected by the total fluid retention, indicating a remarkable vascular
leakage. The experiments were terminated when the total
fluid retention (
Wtot) exceeded 50 g.
As PAP did not exceed 18 mm Hg the formation of hydrostatic edema would not be expected (27). The vascular compliance is found to remain unchanged during HOCl administration indicating that the increase in lung weight is rather due to changes in the microvascular permeability than to increased vascular filling. Perfusate concentrations of potassium and LDH activity (data not shown) show no significant changes as well, implying that the observed effects are not caused by nonspecific cell damage.
PMN Stimulation
Human neutrophils (PMN group: 1,480 ± 323 µl
1, n = 8; CI
group; 1,295 ± 426 µl
1, n = 6) were injected into the arterial
line of the preparation at t =
45 min between two steady
state periods. Cell counts withdrawn from the venous line
(data not shown in detail) demonstrated that more than 95%
of the cells disappeared from the perfusate within the first passage. The neutrophils were stimulated by injection of FMLP
(PMN and CII group: final concentration 1 µM) at t = 0 min.
The results of these experiments are given in Figure 3 and in
Tables 2 and 3. Neither the data measured during baseline hydrostatic challenges (t =
60/t =
15 min) nor the PAP were significantly altered by addition of neutrophils into the perfusate. Only the perfusate MPO-activity increased slightly after
addition of the neutrophils (first arrow) from 2.0 ± 1.5 to 14.9 ± 1.2 mU · L
1 (PMN group) and from 1.7 ± 1.1 to 13.9 ± 1.1 mU · L
1 (CI group) that may be explained by MPO-release
due to cell damage during preparation of neutrophils. The time
course of
PAP as well as the perfusate MPO activity observed during the experiments with stimulated neutrophils
(PMN group) shows a rapid increase after neutrophil stimulation (second arrow). Whereas the pressure rise is almost totally reversible, the perfusate MPO-activity remains increased
during the whole registration time. The time courses of MPO-activity and
PAP of the PMN group differ significantly from
those of control (CI and CII) experiments. CII group experiments show a slight increase in PAP and MPO-activity that
may be explained by stimulation of resident rabbit PMN. A
slight continuous increase in the MPO-activity without any
pressure rise is found in CI group experiments indicating a
continuous MPO-release from unstimulated PMN due to mechanical stress.
|
|
|
The maximum MPO activity (mean 56.1 ± 7.3 mU · L
1,
see Table 3) is measured in the 1-min, 2-min, or 3-min sample.
As shown in Figure 4A, there is a strong correlation between
number of added cells and maximum MPO activity after neutrophil stimulation. The point of intersection between the axis
of ordinates and the regression line (at 23 mU · L
1) indicates
that a basal MPO release should be expected in a system without addition of neutrophils (corresponding to CII). Indeed a
maximum MPO activity of 14.9 ± 2.3 mU · L
1 that may be released from resident rabbit neutrophils is found in control
experiments without neutrophil addition (see Figure 3A control CII).
|
The
PAPmax (mean 8.4 ± 1.1 mm Hg, see Table 3) was
recorded 3.7 ± 0.19 min after neutrophil stimulation. The
PAPmax of every single experiment correlates closely with
the corresponding maximum MPO activity of this experiment (see Figure 4B). The regression line intersects the axis
of ordinates near zero. This extrapolation suggests that there
is no pressure rise without MPO release. Neither the time of
PAPmax nor the time of maximum MPO activity depends on
the cell count.
The effects of neutrophil stimulation on Kf,c,
W, and C
are presented in Table 2. No change in vascular compliance
was found. Only the changes in the t = 60 min values of Kf,c
and
W in the PMN group reached the level of p < 0.05 significance. Kf,c and
W measured during the t = 60 min hydrostatic challenges were increased to 81% and 83% of the
t =
15 min baseline value. Obviously there is a certain increase in vascular permeability that seems to be reversible after 90 min.
Concentration of potassium and LDH activity in the perfusate samples of all experiments did not significantly alter (data not shown in detail). A relevant cell damage therefore might be excluded.
| |
DISCUSSION |
|---|
|
|
|---|
The aim of the study was to characterize the effect of the neutrophil specific oxidant HOCl on pulmonary microvasculature and to compare its effects with the action of stimulated neutrophils.
Continuous HOCl Infusion
HOCl that is formed from hydrogen peroxide by the MPO
acts predominantly via oxidative modification of free functional groups of proteins, especially sulfhydryl groups (19, 20).
HOCl is much more reactive than hydrogen peroxide and its
targets are distinct from those of hydrogen peroxide (18, 20).
HOCl in low concentrations (< 50 µM) has been shown to alter cell membrane function and cellular energy metabolism in a
time and concentration dependent manner (20). Our results
are consistent with these findings concerning the applicated
HOCl concentrations and the dose and time dependence: HOCl
doses that were administered in this study are ranging between 250 and 2,000 nmol · min
1 (perfusate flow 100 ml · min
1) and correspond to HOCl perfusate concentrations between 2.5 and 20 µM. Furthermore the observed effects of
HOCl application are time and dose dependent as well, i.e.,
the effects evoked by larger HOCl doses are stronger and occur earlier. A time and dose dependent depletion of the antioxidative cellular defence may be an explanation of these kinetics. This thesis is supported by the observation that the
product of mean recording time (Table 1) and HOCl dose of
the experiments in which edema formation caused premature
termination (1,000 nmol · min
1 group: 83.7 µmol and 2,000 nmol · min
1 group: 78.8 µmol) shows no significant difference. Thus the application of about 80 µmol HOCl may represent the HOCl dose that causes severe edema formation leading to a premature termination of the experiment in this
isolated protein-free-buffer-perfused organ model that was
used in our study. This dose was not given in the 250 nmol · min
1 and 500 nmol · min
1 group within the recording time of
105 min.
Stimulation of Neutrophils
Neutrophils that were injected into the arterial line rapidly disappeared from the perfusate. Over 95% of the neutrophils were delayed during the first lung passage. This observation is consistent with a variety of reports (22, 23) indicating that even unstimulated PMN adhere to endothelium (1). PMN sequestrated in the lungs may be found as marginated pool of neutrophils in the capillary bed (31) and along the walls of small arteries (2).
In the presented experiments PMN stimulation evoked a
rapid MPO release and pressure rise. There was a strong correlation between maximum MPO-activity and cell count on the
one hand and between
PAPmax and maximum MPO-activity
on the other hand. There are two observations that need further discussion: (1) The perfusate MPO activity increased
slightly to about 15 mU · L
1 after addition of the neutrophils
into the perfusate at
45 min. However this increase did not
influence the
PAP and Kf,c that remained constant during
both steady-state periods. (2) The time course of PAP shows a
short maximum and is almost totally reversible whereas the
perfusate MPO activity remains increased during the whole
registration time. These observations may be explained by the
following considerations: The oxygen burst of FMLP-stimulated neutrophils is characterized by a maximum of oxidant
generation after about one minute and an overall duration of
about 20 to 25 min (32). During the oxygen burst the superoxide radical is formed by the NADPH oxidase and dismutates
spontaneously or enzymatically to hydrogen peroxide that is
the precursor for the MPO mediated HOCl formation. The
mean
PAP (given in Figure 3B) declined from 7.1 ± 0.77 mm
Hg at t = 2.5 min to about 2 mm Hg after 30 min that is the
maximum duration of the neutrophil's oxygen burst after which
no hydrogen peroxide generation and subsequently no HOCl
formation is expected. This observation suggests that MPO
activity without hydrogen peroxide generation does not affect PAP.
Stimulated neutrophils release arachidonic acid metabolites
that may affect the pulmonary microvasculature as well. The
arachidonic acid metabolism of stimulated neutrophils involves
the action of a 5-lipoxygenase on arachidonate to yield a hydroxy-peroxy-intermediate, which is dehydrated to the unstable
epoxide leukotriene A4 (LTA4) or converted to hydroxy-eicosatetraenoic acid. LTA4 is either hydrolized to LTB4 and further metabolized by
-oxidation (considered as a major pathway in PMN) or conjugated to form LTC4 and further cleaved
to form LTD4 and LTE4 (33). However on the one hand LTB4
per se that is released by stimulated PMN is reported to have
no influence on PAP or microvascular permeability (22, 23)
on the other hand LTC4 and D4 that have been shown to
evoke changes in PAP and Kf,c (34) are not synthesized by
PMN alone and need cooperation with other compartments,
i.e., endothelial cells (33). This pathway represents a slow reacting process that does not seem to be an appropriate explanation of the observed rapid pressure rise. However it may explain the increase in Kf,c that is observed after 60 min.
Between 360 and 3,025 neutrophils per µl perfusate were administered in this study, i.e., between about 1.1 and 9.1 · 108 neutrophils per single experiment were infused. The isolation of these numbers of neutrophils from whole blood of rabbits would require whole blood from up to six donor animals, that would not be feasible. The preparation of rabbit peritoneal neutrophils that are isolated after the intraperitoneal injection of a stimulus would provide much more neutrophils per donor animal. However peritoneal neutrophils are isolated after migration into the peritoneal cavum. Although this technique is often used, a functional alteration of these cells can not surely be excluded. Therefore resting human neutrophils were prepared from a sufficient volume of whole blood of one donor per single experiment.
The infusion of human neutrophils into an isolated rabbit lung is an established model as well (15, 33, 35). Human neutrophils are slightly larger than rabbit neutrophils (spherical diameter of resting cells 6.4 ± 0.6 µm versus 6.8 ± 0.8 µm, p < 0.05) and human pulmonary capillaries are slightly but not significantly wider than rabbit pulmonary capillaries (31). A percentage of capillary segments (67% in rabbits, 38% in humans) is too narrow to allow neutrophils to pass through them without deforming the neutrophils. Human neutrophils show a higher deformability than rabbit neutrophils. The ratio between longest and perpendicular diameter increased from 1.1 ± 0.1 (both species) to 6.2 ± 3.0 (human) and 1.9 ± 1.0 (rabbit, p < 0.01) during the passage through the pulmonary capillary bed (31). Therefore a trapping of human neutrophils for mechanical reason is not expected. Moreover, neither an increase in vascular permeability nor a pressure rise was observed after infusion of neutrophils, also indicating that a trapping of these cells for mechanical reasons did not occur.
Importance Under In Vivo Conditions
The study investigates the effect of the neutrophil derived oxidant HOCl and of neutrophil stimulation using an ex vivo isolated buffer perfused organ model. In particular the protein-free buffer medium differs from physiological conditions. The absence of plasma proteins may partially modify the effects of neutrophil derived oxidative stress for the following reasons:
(1) Plasma proteins
in particular albumin
may act as potent oxidant scavengers because of their free functional groups
(i.e., thiol, thioether and amino groups) (18, 19). Therefore
bovine serum albumin that is sometimes used in isolated perfused lung preparations for oncotic reasons (for example 22, 23), may decrease the effects of stimulated neutrophils via oxidant scavenging. However, since the highly reactive oxidant
HOCl acts very locally, it is not expected that all produced
HOCl is inactivated by the reaction with circulating albumin
under physiological circumstances. A certain amount of HOCl
will always attack specific targets in close proximity of stimulated neutrophils. Therefore the presence of albumin is expected to modify quantitatively but not qualitatively HOCl-
induced effects. The infusion of low concentrations of HOCl (as used in this study) into an albumin containing perfusate
would cause an immediate inactivation of the oxidant. Corresponding to others (15, 18, 20, 33) dealing with neutrophil-derived oxidative stress and/or lung injury, we used an albumin free buffer fluid for those reasons.
(2) Other plasma constituents (for example the
1-proteinase-inhibitor) are involved in the regulation of the activity of proteolytic enzymes that are released from neutrophil granules (elastase, serine proteinase, metalloproteinases) (16). The oxidative inactivation of the
1-proteinase-inhibitor due to
HOCl-induced oxidative modification of the critical methionyl
residue (Met-358) and the oxidative activation of metalloproteinases causes a severe perturbation of the proteinase-antiproteinase balance (for review see [16]). This indirect action
of neutrophil-derived oxidative stress is considered a more important in vivo mechanism in the destruction of most tissues
than the direct action of HOCl. However special tissues, like
the lungs and the vascular bed, have an unexpected greater
sensitivity to direct action of oxidants (16). Corresponding to
these data, the present study did not find tissue or cell destruction due to administration of low HOCl-doses that is indicated
by unchanged perfusate potassium and LDH levels. The increase in PAP and Kf,c occurs after administration of very low
HOCl-concentrations (2.5 to 20 µM), whereas tissue destruction and lysis, as described by Weiss (16), were caused by a
HOCl concentration of 70 mM. Therefore the results of our
study may be explained by HOCl-induced alterations of specific cellular functions, like energy metabolism (20), specific
membrane-properties or signal transduction systems (24, 25),
that are usually caused by low oxidant concentrations (20).
The stimulation of neutrophils as well did not cause cell or tissue destruction (as proved by LDH and potassium measurement) even in the absence of plasmatic antiproteases. On the
one hand this lack of proteolytic damage in this isolated lung
model may be explained by a too small number of neutrophils
that only caused effects comparable to those of low HOCl concentrations. On the other hand lung tissue and endothelial structures may show a special susceptibility to oxidative stress as
pointed out by Weiss as well (16). This special susceptibility would explain that the isolated lung model sensitively shows
effects of oxidative stress without any tissue damage due to
proteolytic activity.
Since this study shows no proteolytic effects in the absence of plasmatic antiproteinases, substitution of antiproteinase would not cause specific effects.
Comparison of Both Models of Neutrophil Derived Oxidative Stress
HOCl infusion as well as stimulation of neutrophils that have
been delayed in the pulmonary microvasculature influenced PAP and vascular permeability in an isolated rabbit lung model.
However there are some differences between these models:
(1) Whereas HOCl infusion caused drastic changes in the
vascular permeability and a rather moderate increase in PAP,
stimulation of neutrophils evoked a noticeable pressure rise but
rather slight changes in Kf,c and
W that reached p < 0.05 level of significance only at the t = 60 min value. (2) The pressure rise observed during HOCl infusion started late and increased slowly and continuously whereas the pressure rise
induced by stimulated PMN occurred immediately after stimulation, increased rapidly and was reversible. (3) Changes in
PAP and vascular permeability due to HOCl administration simultaneously occurred whereas the changes in the vascular permeability after PMN stimulation were observed after PAPmax.
These differences may be explained by the different compartments in which the oxidants act on different targets. Oxidants
in particular HOCl as a highly reactive compound
act very locally. Thus, continuous HOCl infusion is expected
to affect primarily the endothelial function and to cause an increased vascular permeability first. After the breakdown of
the endothelial barrier function representing a condition for
the action of HOCl on subendothelial structures, i.e., vascular
smooth muscle cells, a pressure rise may occur. By contrast,
PMN having been delayed in the pulmonary microvasculature
are expected to be found in the capillary bed (31) and in the
walls of small arteries (2). Therefore oxidants released during
an oxygen burst may markedly influence vascular smooth
muscle cells that regulate the vascular tone.
For those reasons the experimental models used in this study are only partially comparable concerning their effect on pulmonary microvasculature.
The effects of continuous HOCl administration as well as of PMN stimulation were not accompanied by a significant increase in perfusate LDH activity and in perfusate potassium concentration. Therefore a significant cell damage can be excluded. This supports the hypothesis that HOCl as nonradical oxidant causes no nonspecific increase in cellular membrane permeability and subsequent cell death that is expected from radical oxidants due to lipid peroxidation. Furthermore our results suggest that low HOCl concentrations cause disturbances of special cellular functions that result in an increase in vascular tone and in a loss of endothelial barrier function. These effects are time and dose dependent and occur after the administration of a certain HOCl dose. This observation suggests that these processes occur after a breakdown of cellular antioxidative defence systems.
HOCl has been proved to be a useful model of oxidative stress that, apart from limitations mentioned above, reproduces the oxidative activity of PMN in the isolated rabbit lung model used in this study. Both models also confirm our hypothesis that PMNs are involved in pulmonary hypertension and edema formation during ARDS via their major oxidant HOCl.
| |
Footnotes |
|---|
The study was supported by a grant of the Leardal Foundation for Acute Medicine.
Correspondence and requests for reprints should be addressed to Stefan Hammerschmidt, M.D., University of Würzburg Dept. of Internal Medicine, Josef-Schneider-Str. 2, D-97080 Würzburg, Germany.
(Received in original form August 9, 1996 and in revised form January 7, 1997).
| |
References |
|---|
|
|
|---|
1. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141: 471-501 [Medline].
2.
Brigham, K. L., and
B. Meyrick.
1984.
Interactions of granulocytes with
the lungs.
Circ. Res.
54:
623-635
3. Divertie, M. B.. 1982. The adult respiratory distress syndrome. Mayo Clin. Proc. 57: 371-378 [Medline].
4. Leeman, M.. 1991. The pulmonary circulation in acute lung injury: a review of some recent advances. Int. Care Med. 17: 254-260 [Medline].
5. Vincent, J. L.. 1995. Is ARDS usually associated with right ventricular dysfunction or failure? Int. Care Med. 21: 195-196 [Medline].
6. Ognibene, F. P., S. E. Martin, M. M. Parker, T. Schlesinger, P. Roach, C. Burch, J. H. Shelhame, and P. Parrillo. 1986. Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med. 315: 547-551 [Abstract].
7. Maunder, R. J., R. C. Hackmann, E. Riff, R. K. Albert, and S. C. Springmeyer. 1986. Occurrence of the adult respiratory distress syndrome in neutropenic patients. Am. Rev. Respir. Dis. 133: 313-316 [Medline].
8. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128: 552-559 [Medline].
9.
Hogg, J. C..
1987.
Neutrophil kinetics and lung injury.
Physiol. Rev.
67:
1249-1295
10.
Simons, R. K.,
R. W. Maier, and
E. S. Lennhard.
1987.
Neutrophil function in a rat model of endotoxin induced lung injury.
Arch. Surg.
122:
197-203
11. Gadek, J. E. 1992. Adverse effects of neutrophils on the lung. Am. J. Med. 92(Suppl. 6A):27S-31S.
12. Fujishima, S., and N. Aikawa. 1995. Neutrophil-mediated tissue injury and its modulation. Int. Care Med. 21: 277-285 [Medline].
13.
Kindt, G. C.,
J. E. Gadek, and
J. E. Weiland.
1991.
Initial recruitment of
neutrophils to alveolar structures in acute lung injury.
J. Appl. Physiol.
70:
1575-1585
14. Weiland, J. E., W. B. Davis, J. F. Holter, et al . 1986. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am. Rev. Respir. Dis. 133: 218-225 [Medline].
15.
Grimminger, F.,
M. Menger,
G. Becker, and
W. Seeger.
1988.
Potentiation of leukotriene production following sequestration of neutrophils in isolated lungs: indirect evidence for intercellular leukotriene A4
transfer.
Blood
72:
1687-1692
16. Weiss, S. J.. 1989. Tissue destruction by neutrophils. N. Eng. J. Med. 320: 365-376 [Medline].
17. Fantone, J. C., and P. A. Ward. 1982. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. Ass. Pathologists 107: 397-418 .
18. Fliss, H.. 1988. Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants. Mol. Cell. Biochem. 84: 177-188 [Medline].
19. Arnhold, J., S. Hammerschmidt, and K. Arnold. 1991. Role of functional groups of human plasma and luminol in scavenging of NaOCl and neutrophil-derived hypochlorous acid. Biochim. Biophys. Acta 1097: 145-151 [Medline].
20. Schraufstätter, I. U., K. Browne, A. Harris, P. A. Hyslop, J. H. Jackson, O. Quehenberger, and C. G. Cochrane. 1990. Mechanisms of hypochlorite injury of target cells. J. Clin. Invest. 85: 554-562 .
21. McDonald, R. F., E. M. Berger, and J. E. Repine. 1987. Neutrophil- derived oxygen metabolites stimulate thromboxane release, pulmonary artery pressure increase, and weight gains in isolated perfused rat lungs. Am. Rev. Respir. Dis. 135: 957-959 [Medline].
22.
Tanaka, H.,
J. D. Bradley,
L. J. Baudendstiel, and
T. E. Dahms.
1992.
Mechanisms of pulmonary vasoconstriction induced by chemotactic
peptide FMLP in isolated rabbit lungs.
J. Appl. Physiol.
72:
1549-1556
23.
Tanaka, H.,
J. D. Bradley,
L. J. Baudendstiel, and
T. E. Dahms.
1992.
Mechanisms of increased pulmonary microvascular permeability induced by FMLP in isolated rabbit lungs.
J. Appl. Physiol.
73:
2074-2082
24. Tate, R. M., H. G. Morris, W. R. Schroeder, and J. E. Repine. 1984. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline perfused rabbit lungs. J. Clin. Invest. 74: 608-613 .
25. Burghuber, O. C., R. J. Strife, J. Zirrolli, P. M. Henson, J. E. Henson, M. M. Mathias, J. T. Reeves, R. C. Murphy, and N. F. Voelkel. 1985. Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. Am. Rev. Respir. Dis. 131: 778-785 [Medline].
26. Tate, R. M., K. M. van Benthuysen, D. M. Shasby, I. F. McMurtry, and J. E. Repine. 1982. Oxygen-radical-mediated permeability edema and vasocontriction in isolated perfused rabbit lungs. Am. Rev. Respir. Dis. 126: 802-806 [Medline].
27.
Seeger, W.,
D. Walmrath,
M. Menger, and
H. Neuhof.
1986.
Increased lung vascular permeability after arachidonic acid and hydrostatic challenge.
J. Appl. Physiol.
61:
1781-1789
28. Richardson, P. D. I., D. N. Granger, and E. Taylor. 1979. Capillary filtration coefficient: the technique and its application to the small intestine. Cardiovasc. Res. 13: 547-561 [Medline].
29. Morris, J. C. 1966. The acid ionization constant of HOCl from 5 to 35°C. J. Physic. Chem. 70 No. 12:3798-3805.
30. Klebanoff, S. J., A. M. Waltersdorph, and H. Rosen. 1984. Antimicrobial activity of myeloperoxidase. Meth. Enzymol. 105: 399-403 [Medline].
31.
Doerschuk, M. D.,
N. Beyers,
H. O. Coxson,
B. Wiggs, and
J. C. Hogg.
1993.
Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung.
J. Appl. Physiol.
74:
3040-3045
32. Dahlgren, C.. 1987. Polymorphonuclear leukocyte chemiluminescence induced by formyl-methionyl-leucyl-phenylalanin and phorbol myristate acetate: effects of catalase and superoxide dismutase. Agents Actions 21: 104-112 [Medline].
33.
Grimminger, F.,
B. Kreusler,
U. Schneider,
G. Becker, and
W. Seeger.
1990.
Influence of microvascular adherence on neutrophil leukotriene
generation
evidence for cooperative eicosanoid synthesis.
J. Immunol.
144:
1866-1872
[Abstract].
34.
Voelkel, N. F.,
K. R. Sternmark,
J. T. Reeves,
M. M. Maathial, and
R. C. Murphy.
1984.
Actions of lipoxygenase metabolites in isolated rat
lungs.
J. Appl. Physiol.
57:
860-867
35.
Shasby, D. M.,
S. S. Shasby, and
M. J. Peach.
1985.
Polymorphonuclear
leukocyte: arachidonate edema.
J. Appl. Physiol.
59:
47-55
This article has been cited by other articles:
![]() |
M. T. Schley, M. Casutt, C. Haberthur, M. Dusch, R. Rukwied, M. Schmelz, J. Schmeck, G. K. Schupfer, and C. J. Konrad Long-Acting Local Anesthetics Attenuate FMLP-induced Acute Lung Injury in Rats Anesth. Analg., September 1, 2009; 109(3): 880 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Lagan, D. D. Melley, T. W. Evans, and G. J. Quinlan Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L161 - L174. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Wahn, N Ruenauver, and S Hammerschmidt Effect of arachidonic and eicosapentaenoic acids on acute lung injury induced by hypochlorous acid Thorax, December 1, 2002; 57(12): 1060 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hammerschmidt, N. Buchler, and H. Wahn Tissue Lipid Peroxidation and Reduced Glutathione Depletion in Hypochlorite-Induced Lung Injury Chest, February 1, 2002; 121(2): 573 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pullar, C. C. Winterbourn, and M. C. M. Vissers Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1505 - H1512. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |